Prescribing for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) for Children Young People and Adults

Warning

** This guideline is currently under review**

Please continue to use this document as the current guidance.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 19/08/2021

Next review date: 30/06/2023

Author(s): NHS Lanarkshire.

Version: V3.0

Approved By: Mehrdad Malekian | Mental Health & Learning Disabilities Drug & Therapeutic Committee

Reviewer name(s): Lorna Templeton | Naomi Booker.